| Nome |
# |
|
Natural history and risk factors for diabetic kidney disease in patients with T2D: lessons from the AMD-annals, file e268c4cb-f663-a6b7-e053-3a05fe0adea1
|
507
|
|
Peripheral artery disease and blood pressure profile abnormalities in hemodialysis patients, file e268c4cb-f659-a6b7-e053-3a05fe0adea1
|
228
|
|
Effects of dual inhibition of renin–angiotensin–aldosterone system on cardiovascular and renal outcomes: balancing the risks and the benefits, file e268c4cc-3008-a6b7-e053-3a05fe0adea1
|
182
|
|
Association of kidney disease measures with risk of renal function worsening in patients with type 1 diabetes, file e268c4c9-95a7-a6b7-e053-3a05fe0adea1
|
138
|
|
Achievement of therapeutic targets in patients with diabetes and chronic kidney disease: Insights from the Associazione Medici Diabetologi Annals initiative, file e268c4cb-211a-a6b7-e053-3a05fe0adea1
|
120
|
|
Diabetic kidney disease in the elderly: Prevalence and clinical correlates, file e268c4ca-44af-a6b7-e053-3a05fe0adea1
|
117
|
|
Uric Acid Promotes Apoptosis in Human Proximal Tubule Cells by Oxidative Stress and the Activation of NADPH Oxidase NOX 4, file e268c4c7-3246-a6b7-e053-3a05fe0adea1
|
114
|
|
Novelty in hypertension in children and adolescents: Focus on hypertension during the first year of life, use and interpretation of ambulatory blood pressure monitoring, role of physical activity in prevention and treatment, simple carbohydrates and uric acid as risk factors, file e268c4c7-3083-a6b7-e053-3a05fe0adea1
|
106
|
|
Antihyperglycemic treatment in patients with type 2 diabetes in Italy: The impact of age and kidney function, file e268c4ca-40f7-a6b7-e053-3a05fe0adea1
|
104
|
|
Metabolic syndrome, serum uric acid and renal risk in patients with T2D, file e268c4c7-de51-a6b7-e053-3a05fe0adea1
|
100
|
|
Blood pressure variability and multiple organ damage in primary hypertension, file e268c4c6-b58f-a6b7-e053-3a05fe0adea1
|
98
|
|
Predictors of chronic kidney disease in type 2 diabetes: A longitudinal study from the AMD Annals initiative, file e268c4c7-2ac2-a6b7-e053-3a05fe0adea1
|
97
|
|
Toll-like receptor 4 signalling mediates inflammation in skeletal muscle of patients with chronic kidney disease, file e268c4c7-de72-a6b7-e053-3a05fe0adea1
|
96
|
|
Normoalbuminuric kidney impairment in patients with T1DM: Insights from annals initiative, file e268c4ca-854a-a6b7-e053-3a05fe0adea1
|
91
|
|
Uric acid in CKD: has the jury come to the verdict?, file e268c4cb-f259-a6b7-e053-3a05fe0adea1
|
91
|
|
Five-Year Predictors of Insulin Initiation in People with Type 2 Diabetes under Real-Life Conditions, file e268c4c9-9106-a6b7-e053-3a05fe0adea1
|
90
|
|
Antihypertensive Treatment in Diabetic Kidney Disease: The Need for a Patient-Centered Approach, file e268c4ca-2d9d-a6b7-e053-3a05fe0adea1
|
89
|
|
Apparent Treatment Resistant Hypertension, Blood Pressure Control and the Progression of Chronic Kidney Disease in Patients with Type 2 Diabetes, file e268c4ca-6d06-a6b7-e053-3a05fe0adea1
|
85
|
|
The Organ Handling of Soluble Klotho in Humans, file e268c4ca-fac8-a6b7-e053-3a05fe0adea1
|
83
|
|
Publisher Correction: Predictors of chronic kidney disease in type 1 diabetes: a longitudinal study from the AMD Annals initiative, file e268c4cb-d345-a6b7-e053-3a05fe0adea1
|
76
|
|
Resistant Hypertension, Time-Updated Blood Pressure Values and Renal Outcome in Type 2 Diabetes Mellitus, file e268c4ca-84d6-a6b7-e053-3a05fe0adea1
|
65
|
|
New Treatment Options for Hyperkalemia in Patients with Chronic Kidney Disease, file e268c4cc-9558-a6b7-e053-3a05fe0adea1
|
65
|
|
Kidney dysfunction and related cardiovascular risk factors among patients with type 2 diabetes, file e268c4ca-3111-a6b7-e053-3a05fe0adea1
|
64
|
|
Atherogenic dyslipidemia and diabetic nephropathy, file e268c4cd-0861-a6b7-e053-3a05fe0adea1
|
61
|
|
Insulin sensitivity of muscle protein metabolism is altered in patients with chronic kidney disease and metabolic acidosis., file e268c4c6-b162-a6b7-e053-3a05fe0adea1
|
56
|
|
null, file e268c4cc-8229-a6b7-e053-3a05fe0adea1
|
53
|
|
null, file e268c4cc-2cc2-a6b7-e053-3a05fe0adea1
|
50
|
|
Association of uric acid with kidney function and albuminuria: the Uric Acid Right for heArt Health (URRAH) Project, file e268c4cd-fd1d-a6b7-e053-3a05fe0adea1
|
33
|
|
The control of muscle protein turnover in patients on peritoneal dialys, file e268c4ca-83a0-a6b7-e053-3a05fe0adea1
|
32
|
|
Longitudinal Cluster Analysis of Hemodialysis Patients with COVID-19 in the Pre-Vaccination Era, file f5e550fa-3dae-4870-b05c-14da074e25ef
|
19
|
|
Enhanced myostatin expression and signalling promote tubulointerstitial inflammation in diabetic nephropathy, file e268c4cd-6991-a6b7-e053-3a05fe0adea1
|
12
|
|
Management of COVID-19 in hemodialysis patients: The Genoa experience, file e268c4ce-099e-a6b7-e053-3a05fe0adea1
|
9
|
|
null, file e268c4cd-7625-a6b7-e053-3a05fe0adea1
|
8
|
|
Fructose and uric acid: Major mediators of cardiovascular disease risk starting at pediatric age, file e268c4cc-9559-a6b7-e053-3a05fe0adea1
|
7
|
|
Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis, file e268c4cc-b7e9-a6b7-e053-3a05fe0adea1
|
6
|
|
Publisher Correction: Predictors of chronic kidney disease in type 1 diabetes: a longitudinal study from the AMD Annals initiative, file e268c4cb-0ed2-a6b7-e053-3a05fe0adea1
|
5
|
|
null, file e268c4ca-19cf-a6b7-e053-3a05fe0adea1
|
4
|
|
Uric acid and angiotensin II additively promote inflammation and oxidative stress in human proximal tubule cells by activation of toll-like receptor 4., file e268c4ca-44b7-a6b7-e053-3a05fe0adea1
|
4
|
|
Role of Uric Acid in Vascular Remodeling: Cytoskeleton Changes and Migration in VSMCs, file c6660f72-56d7-43b0-886c-357ab292d68a
|
3
|
|
Ultrasound Doppler renal resistive index: a useful tool for the management of the hypertensive patient, file e268c4c6-b7b2-a6b7-e053-3a05fe0adea1
|
3
|
|
Serum uric acid levels predict new onset type 2 diabetes in hospitalized patients with primary hypertension: the MAGIC study., file e268c4c6-c0d1-a6b7-e053-3a05fe0adea1
|
3
|
|
Mild hyperuricemia and subclinical renal damage in untreated primary hypertension, file e268c4c7-36d6-a6b7-e053-3a05fe0adea1
|
3
|
|
GLP-1 Receptor Agonists and Kidney Protection, file e268c4cb-407b-a6b7-e053-3a05fe0adea1
|
3
|
|
Ten-Year Efficacy and Safety of Once-Daily Tacrolimus in Kidney Transplant: A Prospective Cohort Study, file e268c4cc-5764-a6b7-e053-3a05fe0adea1
|
3
|
|
Treating Hyperuricemia: The Last Word Hasn't Been Said Yet, file e268c4ce-116e-a6b7-e053-3a05fe0adea1
|
3
|
|
Two-Day ABPM-Derived Indices and Mortality in Hemodialysis Patients, file e268c4ce-13cd-a6b7-e053-3a05fe0adea1
|
3
|
|
Relationship between uric acid and kidney function in adults at risk for tumor lysis syndrome, file 0768f9f1-9a85-4aff-9307-0465b77e5ae3
|
2
|
|
Extracorporeal Carbon Dioxide Removal: From Pathophysiology to Clinical Applications; Focus on Combined Continuous Renal Replacement Therapy, file 1f55895f-7bb5-49b7-a40e-c87064f7c42b
|
2
|
|
Kidney disease and all-cause mortality in patients with COVID-19 hospitalized in Genoa, Northern Italy, file 289f0df2-993e-441f-8b16-3d0cac2a001d
|
2
|
|
Diagnosing Fabry nephropathy: the challenge of multiple kidney disease, file 5c937967-8cb6-445b-8ce2-6ca5aeefbfb3
|
2
|
|
Kidney Transplantation in a Patient Affected by Sickle Cell Trait: A Case Report and State-of-the-Art Review, file a8e3a04e-cbc9-430c-912f-da25ce518f77
|
2
|
|
Multifaceted relationship between diabetes and kidney diseases: Beyond diabetes, file d88d1c1d-243c-4c93-8d40-3b59f4a3ca12
|
2
|
|
Sub-clinical organ damage in hypertension and obesity, file e268c4c6-12e6-a6b7-e053-3a05fe0adea1
|
2
|
|
Serum uric acid and risk of CKD in type 2 diabetes, file e268c4c6-aeeb-a6b7-e053-3a05fe0adea1
|
2
|
|
The liver and the kidney: two critical organs influencing the atherothrombotic risk in metabolic syndrome., file e268c4c6-b7e4-a6b7-e053-3a05fe0adea1
|
2
|
|
Blood pressure status and the incidence of diabetic kidney disease in patients with hypertension and type 2 diabetes, file e268c4c7-2f31-a6b7-e053-3a05fe0adea1
|
2
|
|
Longitudinal Association between Serum Uric Acid and Arterial Stiffness: Results from the Baltimore Longitudinal Study of Aging, file e268c4c7-e64c-a6b7-e053-3a05fe0adea1
|
2
|
|
Antihypertensive treatment and renal protection: Is there a J-curve relationship?, file e268c4c9-9104-a6b7-e053-3a05fe0adea1
|
2
|
|
Epidemiology of diabetic kidney disease in adult patients with type 1 diabetes in Italy: The AMD-Annals initiative, file e268c4ca-1681-a6b7-e053-3a05fe0adea1
|
2
|
|
Interorgan handling of fibroblast growth factor-23 in humans, file e268c4ca-1683-a6b7-e053-3a05fe0adea1
|
2
|
|
Increased urine semaphorin-3A is associated with renal damage in hypertensive patients with chronic kidney disease: a nested case-control study, file e268c4ca-44c0-a6b7-e053-3a05fe0adea1
|
2
|
|
Trend of eGFR in an Italian cohort of mother-to-child HIV-infected patients exposed to tenofovir for at least 2 years., file e268c4ca-467f-a6b7-e053-3a05fe0adea1
|
2
|
|
Blood pressure reduction and RAAS inhibition in diabetic kidney disease: therapeutic potentials and limitations, file e268c4cc-cc8a-a6b7-e053-3a05fe0adea1
|
2
|
|
Outcomes on safety and efficacy of left atrial appendage occlusion in end stage renal disease patients undergoing dialysis, file e268c4cc-ce4e-a6b7-e053-3a05fe0adea1
|
2
|
|
How to Overcome Anabolic Resistance in Dialysis-Treated Patients?, file e268c4cd-e7f7-a6b7-e053-3a05fe0adea1
|
2
|
|
Sglt2is and renal protection: From biological mechanisms to real-world clinical benefits, file e268c4cd-fd1f-a6b7-e053-3a05fe0adea1
|
2
|
|
The Results of the URRAH (Uric Acid Right for Heart Health) Project: A Focus on Hyperuricemia in Relation to Cardiovascular and Kidney Disease and its Role in Metabolic Dysregulation, file 28eacd80-1d9a-4f4e-97de-d3760f7a3a46
|
1
|
|
First detection of μ-plastics in human urines and kidneys using μ-Raman spectroscopy, file 4b65b9d1-e11d-49e6-9dfb-2445fb7e5763
|
1
|
|
Future directions of maintenance therapy in ANCA-associated vasculitis, file a8ae697b-4791-47a8-be3e-13b4b6b65365
|
1
|
|
Microalbuminuria is a predictor of chronic renal insufficiency in patients without diabetes and with hypertension: the MAGIC Study, file e268c4c5-f904-a6b7-e053-3a05fe0adea1
|
1
|
|
Increased ambulatory arterial stiffness index is associated with target organ damage in primary hypertension, file e268c4c5-f97a-a6b7-e053-3a05fe0adea1
|
1
|
|
Combined effect of albuminuria and estimated glomerular filtration rate on cardiovascular events and all-cause mortality in uncomplicated hypertensive patients, file e268c4c5-fa08-a6b7-e053-3a05fe0adea1
|
1
|
|
Renal and cardiac abnormalities in primary hypertension, file e268c4c5-fb03-a6b7-e053-3a05fe0adea1
|
1
|
|
Chronic kidney disease in hypertension under specialist care: the I-DEMAND study, file e268c4c5-fb93-a6b7-e053-3a05fe0adea1
|
1
|
|
Inappropriate left ventricular mass is associated with microalbuminuria independently of left ventricular hypertrophy in primary hypertension, file e268c4c6-11d2-a6b7-e053-3a05fe0adea1
|
1
|
|
Global risk stratification in primary hypertension: the role of the kidney, file e268c4c6-11ec-a6b7-e053-3a05fe0adea1
|
1
|
|
Coronary flow reserve is impaired in hypertensive patients with subclinical renal damage, file e268c4c6-11ed-a6b7-e053-3a05fe0adea1
|
1
|
|
Mild renal dysfunction and renal vascular resistance in primary hypertension, file e268c4c6-13cc-a6b7-e053-3a05fe0adea1
|
1
|
|
Ambulatory arterial stiffness index and renal abnormalities in primary hypertension, file e268c4c6-13d7-a6b7-e053-3a05fe0adea1
|
1
|
|
Serum uric acid and its relationship with metabolic syndrome and cardiovascular risk profile in patients with hypertension: insights from the I-DEMAND study, file e268c4c6-b623-a6b7-e053-3a05fe0adea1
|
1
|
|
Serum Uric Acid and Blood Pressure in Children at Cardiovascular Risk, file e268c4c6-c0d7-a6b7-e053-3a05fe0adea1
|
1
|
|
Vitamin D modulates the association of circulating insulin-like growth factor-1 with carotid artery intima-media thickness, file e268c4c6-c47e-a6b7-e053-3a05fe0adea1
|
1
|
|
Metabolic syndrome is associated with left ventricular dilatation in primary hypertension, file e268c4c7-3081-a6b7-e053-3a05fe0adea1
|
1
|
|
Changes in albuminuria and cardiovascular risk under antihypertensive treatment: a systematic review and meta-regression analysis, file e268c4c7-31bf-a6b7-e053-3a05fe0adea1
|
1
|
|
Chronic kidney disease as a predictor of clinical risk in the elderly, file e268c4c7-3337-a6b7-e053-3a05fe0adea1
|
1
|
|
Albuminuria: The kidney message on cardiovascular health, file e268c4c7-34ca-a6b7-e053-3a05fe0adea1
|
1
|
|
Can we predict outcome by noninvasive assessment of renal haemodynamics in hypertension? The role of renal resistive index, file e268c4c7-34cb-a6b7-e053-3a05fe0adea1
|
1
|
|
Plasma Triglycerides and HDL-C Levels Predict the Development of Diabetic Kidney Disease in Subjects With Type 2 Diabetes: The AMD Annals Initiative, file e268c4c7-35ed-a6b7-e053-3a05fe0adea1
|
1
|
|
Predicting cardiovascular risk using creatinine clearance and an artificial neural network in primary hypertension, file e268c4c7-3607-a6b7-e053-3a05fe0adea1
|
1
|
|
Microalbuminuria in primary hypertension: a guide to optimal patient management?, file e268c4c7-383e-a6b7-e053-3a05fe0adea1
|
1
|
|
Prevalent cardiac, renal and cardiorenal damage in patients with advanced abdominal aortic aneurysms, file e268c4c7-3eb4-a6b7-e053-3a05fe0adea1
|
1
|
|
Association of kidney disease measures with risk of renal function worsening in patients with hypertension and type 2 diabetes, file e268c4c7-e896-a6b7-e053-3a05fe0adea1
|
1
|
|
Long-term blood pressure variability and development of chronic kidney disease in type 2 diabetes, file e268c4c9-aeb6-a6b7-e053-3a05fe0adea1
|
1
|
|
Overall Quality of Care Predicts the Variability of Key Risk Factors for Complications in Type 2 Diabetes: An Observational, Longitudinal Retrospective Study, file e268c4c9-d0d2-a6b7-e053-3a05fe0adea1
|
1
|
|
Toll-like receptor-4 signaling mediates inflammation and tissue injury in diabetic nephropathy, file e268c4ca-1685-a6b7-e053-3a05fe0adea1
|
1
|
|
The uric acid cardio-nephropathy - La cardionefropatia da acido urico, file e268c4ca-1687-a6b7-e053-3a05fe0adea1
|
1
|
|
Variability in HbA1c, blood pressure, lipid parameters and serum uric acid, and risk of development of chronic kidney disease in type 2 diabetes, file e268c4ca-1689-a6b7-e053-3a05fe0adea1
|
1
|
|
null, file e268c4ca-1a58-a6b7-e053-3a05fe0adea1
|
1
|
|
Hyperuricemia and renal risk - Iperuricemia e rischio renale, file e268c4ca-2ead-a6b7-e053-3a05fe0adea1
|
1
|
|
Kidney disease measures are associated with the burden of coronary atherosclerosis, independently of diabetes, file e268c4ca-40fb-a6b7-e053-3a05fe0adea1
|
1
|
| Totale |
3.263 |